Marshall Goldsmith

FEBRUARY 8, 2018

Authority on new technology and communication. Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. World leading researcher on the impact of leadership in organizations. Leads Tuck’s incredibly innovative coaching program.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Strategy Driven

NOVEMBER 29, 2016

Always at the forefront of innovation, technologies pioneered by the military are often adopted by the commercial sector; companies looking for cyber knowledge or network engineering skills can find this expertise among veterans.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 9

Innovation Short-term Telecommunications Long-term 9

Strategy Driven

JULY 13, 2011

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). As with the other measures, what is important varies by industry.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

JUNE 7, 2012

Take technology providers' technical support, with its long hold times "hopelessly complex interactions." Pharmaceutical patent expirations are increasing the use of cheaper generic drugs. What Impact Will Facebook Have on Organ Donations? Looking to take an unsuspecting industry by storm? BONUS BITS: Life-Saving Goes Social.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. The truth is that some of the problems we face today are simply too big and complex to be solved by any one organization. Innovating the Innovation Process. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 15

Health Care Innovation Pharmaceuticals Consensus 15

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

FEBRUARY 11, 2016

But most organizations aren’t set up for getting the most out of non-traditional employment relationships. In this excerpt from their book, Agile Talent , Younger and Smallwood explain how to align your organization with the needs and expectations of a workforce that is increasingly external, project-based, and flexible.

Agility 8

Agility Organization Resources Fixed Costs 8

Harvard Business Review

JUNE 7, 2012

Take technology providers' technical support, with its long hold times "hopelessly complex interactions." Pharmaceutical patent expirations are increasing the use of cheaper generic drugs. What Impact Will Facebook Have on Organ Donations? Looking to take an unsuspecting industry by storm? BONUS BITS: Life-Saving Goes Social.

Disruptive Innovation 12

Disruptive Innovation Innovation Pharmaceuticals Class 12

Harvard Business Review

OCTOBER 26, 2017

Today when we talk about business “ clusters ,” we’re usually talking about the technology industry in Silicon Valley, the financial sector in London or New York, or automakers in southern Germany. The major innovation lay in an extraordinary machine already in use in Lucca, about 150 kilometers southwest of Bologna.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. The translation involves people and processes.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

MAY 26, 2014

But ongoing changes in policy, technology, and industry culture are now creating unprecedented opportunities for those with just the right kind of crazy. Four dynamics are driving this new era of health care innovation: Finally, there is a financial incentive to innovate. Consumer technology offers direct access to patients.

Health Care 8

Health Care Venture Funding Entrepreneur Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 5, 2016

The concept is fairly straightforward: The parties define the result up front, agree on a baseline, work out how confident the organization is in delivering the result, and then specify the expectation and payment in the contract. There is enough time to develop innovative solutions to achieve the results. Samuel Castro.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

SEPTEMBER 13, 2012

Managers and business analysts will often be called upon to conduct data-driven experiments, to interpret data, and to create innovative data-based products and services. Procter & Gamble's CEO, Bob McDonald, is convinced that "data modeling, simulation, and other digital tools are reshaping how we innovate." BIG DATA INSIGHT CENTER.

Skills 16

Skills Pharmaceuticals Sample Business Intelligence 16

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

APRIL 2, 2018

We invest billions of dollars each year in medicines, new technologies, doctors, and hospitals—all with the goal of improving health, arguably our most prized commodity. So reducing investments in low-value care services means spending less on doctors, hospitals, and other health care technologies. rawpixel/Getty Images.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JUNE 6, 2011

5th Place: SmarterShade from Notre Dame created an elegant technology that adjusts the tint on windows, saving on building cooling costs by preventing heat gain. TNG Pharmaceuticals from University of Louisville developed a vaccine for a parasite that strikes cattle, costing the dairy and beef industry over $1 billion a year.

Pharmaceuticals 14

Pharmaceuticals Entrepreneur Industry Energy 14

Harvard Business Review

JANUARY 12, 2017

Organizations striving to find new ways to attack cancer have much to learn from direct-to-consumer (DTC) companies. Advances in genome-sequencing technologies and powerful analytics are increasingly being used to pinpoint errant genes and other molecular abnormalities that drive cancer’s growth. Know the patient. If so, how?

Company 8

Company Health Care Storytelling Pharmaceuticals 8

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. This is the kind of technology—and the type of firm—that will make renewable energy more efficient and more cost-effective. competitiveness and growth in the 21 st century.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

MARCH 6, 2012

Technological innovation accounted for almost half of U.S. economic growth over the past 50 years, but the country's standing as the world's indisputable innovation leader is now at risk. At Merck, as part of our commitment to scientific innovation, we are working to foster the next generation of scientific leaders.

Education 11

Education Creativity How To Pharmaceuticals 11

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8

Harvard Business Review

MARCH 9, 2015

Advances in digital technology and their use in organizations carry huge promise to empower people at all levels. Social media and collaboration tools not only open the door to faster and more extensive knowledge-sharing, but they also enable conversations that skip levels, silo-busting, and self-organization.

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

DECEMBER 27, 2016

Healthcare has become extraordinarily complex — the balance of quality against cost, and of technology against humanity, are placing ever-increasing demands on clinicians. The course culminates in a team-based innovation project presented to hospital leadership. These challenges require extraordinary leaders.

Management 14

Management 360-Degree Feedback Mayo Training 14

Harvard Business Review

APRIL 22, 2013

We live in a world in which amplified individuals — people empowered by technologies and the collective intelligence of their social networks — can do things that previously only a large organization could. Indeed, they can do some things that no organization could do before.

Mission Statement 8

Mission Statement Class Learning-by-Doing Pharmaceuticals 8

Harvard Business Review

JANUARY 8, 2013

Breaking down functional silos is key to everything from encouraging communication to building valuable connections to sparking innovation. arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). "The But, as we all know, bridging interdepartmental chasms is far easier said than done.

Company 8

Company Pharmaceuticals Health Care Participative 8

Harvard Business Review

NOVEMBER 1, 2017

We studied Omada’s program as part of our Harvard Medical School initiative to identify and share knowledge about innovative approaches to major health challenges that primary care providers play the lead in treating. The course usually consists of weekly sessions during the initial four months.

Health Care 11

Health Care Participative Wireless Pharmaceuticals 11

Harvard Business Review

APRIL 24, 2017

In addition to homing in on targeted research and development efforts, governments have a unique obligation to work with the international community, such as the World Health Organization, to ensure a common response framework is in place, particularly in fragile states, whose health systems are underdeveloped. Science/technology community.

Project 8

Project Disaggregation Globalization Comparison 8

Harvard Business Review

MAY 17, 2012

According to the World Health Organization, 75% of these deaths and ailments could be averted by simply keeping these premature babies warm. Enter jugaad innovation — a cost-effective approach for creating affordable products and services using limited resources. For us, innovation is a dynamic process that never ends.''.

Incubator 11

Incubator Business Model Entrepreneur Cost 11

Strategy Driven

MARCH 18, 2011

Large downturns (such as this recession), technology disruptions, or regulatory shifts create discontinuities that simply accelerate the industry’s evolution toward this equilibrium state. These organizations move in lockstep, because everyone understands what’s important. The leading companies are getting out in front of this trend.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

FEBRUARY 4, 2013

Our research with members of the global C-suite, and with leading sustainability and innovation experts, has identified seven vectors of breakthrough change. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Governments, investors and the social innovation sector should support them to the hilt.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

JUNE 14, 2017

How the most innovative providers are creating value. The bulk of HCIT investment supports startups that sell data — clinical or operational information that is otherwise difficult for clients to obtain or to organize. Sponsored by Optum. Yet too many HCIT providers are still pursuing that data-centric advantage. demographics.

Health Care 8

Health Care Levitt Competitive Advantage Pharmaceuticals 8

Harvard Business Review

JANUARY 15, 2013

By inextricably linking the two, we confine the practice of real, turbo-charged capitalism to business, and we dangerously limit the capacity of non-business organizations to innovate, fund, and bring to scale the kind of breakthrough ideas that will begin to solve the huge social problems we face today.

Learning Curve 8

Learning Curve Advertising GDP Pharmaceuticals 8

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. But the problem of getting different parts of organizations to talk meaningfully with one another is old. paul Garbett for HBR. In five years, the revenue shortfall would be significant.

Leadership 9

Leadership Diversity Committee Long-term 9

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. “Japanese leaders recognize the importance of encouraging medical innovation,” Eli Lilly and Co. Older people need more medicine.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Content 8

Harvard Business Review

SEPTEMBER 20, 2013

Content Innovation. Fortunately, the organizations that took the effort to truly understand the value of their data were able to execute appropriately. Fortunately, the organizations that took the effort to truly understand the value of their data were able to execute appropriately. In some cases, they’re right.

Execution 8

Execution Metrics Content Christensen 8